Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 mg Tablets in Healthy Volunteers.
Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 mg Tablets in Healthy Volunteers.
Recruiting · NCT07421011 · Registry updated 2026-02-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 mg Tablets in Healthy Volunteers. | Deglutition Disorders, Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, bile duct disorder, biliary dyskinesia, biliary tract disorder, cholelithiasis, colonic disorder, common bile duct disorder, digestive system disorder, dyskinesia of esophagus, esophageal disorder, functional colonic disease, gastroesophageal reflux disease, intestinal disorder, irritable bowel syndrome, postcholecystectomy syndrome | Recruiting | Phase 1 | 2026-02-19 | NCT07421011 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Valenta Pharm JSC | 12 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Federal Budgetary Institution of Science "North-West Public Health Research Center" | Saint Petersburg | Russia | 2 |